Fauci: Don't Assume Chloroquine is a 'Knockout Drug'; Vaccine is 'Ultimate Game Changer'Chris Menahan
Apr. 03, 2020
'Q-Anon' Bears Striking Resemblance to Bolshevik Psy-Op From 1920s Known As 'Operation Trust'
'Normalcy' Returns: Biden Sends Large Military Convoy Into Syria On Day Two
'We Feel Incredibly Betrayed': National Guard Troops Kicked To The Curb After Biden Inauguration
Trump Pardons Sholam Weiss, Criminal Mastermind Behind 'The Largest Life Insurance Fraud In U.S. History'
Banking Blockade: Another Bank Just Announced They're Closing Trump's Accounts
Don't assume hydroxychloroquine is a "knockout drug" but do assume a theoretical vaccine rushed out in just a year or so with little testing is an "ultimate game changer."
From CNBC, "Coronavirus: Dr. Anthony Fauci warns Americans shouldn't assume hydroxychloroquine is a 'knockout drug'":
Americans shouldn't assume hydroxychloroquine is a "knockout drug" in preventing or treating COVID-19, White House health advisor Dr. Anthony Fauci warned Friday.As the Washington Times reported yesterday, an international survey of 6,227 doctors in 30 countries found hydroxychloroquine or chloroquine was rated as the "most effective therapy" overall.
It's worth noting that Fauci has not spent any money to launch trials for hydroxychloroquine or chloroquine but has spent money on trials for Gilead's Remdesivir.
Incidentally, chloroquine is about .04 cents per dose internationally, which would come out to less than $1 per course, whereas analysts are predicting Remdesivir will cost around $1,000 per course.
Fortunately, hydroxychloroquine is being given trials by the government of France and private industry is funding trials in America.
Last month, Reuters reported that rushing a vaccine can have disastrous consequences:
Behind the scenes, scientists and medical experts are concerned that rushing a vaccine could end up worsening the infection in some patients rather than preventing it.I think I'd rather take my chances with hydroxychloroquine.
Follow InformationLiberation on Twitter, Facebook, Gab and Minds.